- Report
- September 2023
- 110 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- June 2024
- 145 Pages
Global
From €2239EUR$2,500USD£1,909GBP
- Report
- May 2025
- 85 Pages
India
From €2665EUR$2,975USD£2,271GBP
€3135EUR$3,500USD£2,672GBP
- Report
- August 2024
- 82 Pages
Japan
From €2665EUR$2,975USD£2,271GBP
€3135EUR$3,500USD£2,672GBP
- Report
- April 2024
- 85 Pages
India
From €2665EUR$2,975USD£2,271GBP
€3135EUR$3,500USD£2,672GBP
From €2665EUR$2,975USD£2,271GBP
€3135EUR$3,500USD£2,672GBP
- Report
- November 2023
- 178 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- October 2023
- 89 Pages
Malaysia
From €2665EUR$2,975USD£2,271GBP
€3135EUR$3,500USD£2,672GBP
- Report
- September 2023
- 200 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- August 2023
- 76 Pages
Egypt
From €2665EUR$2,975USD£2,271GBP
€3135EUR$3,500USD£2,672GBP
- Report
- October 2021
- 78 Pages
United States
From €2665EUR$2,975USD£2,271GBP
€3135EUR$3,500USD£2,672GBP
- Report
- February 2024
- 132 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- April 2023
- 75 Pages
Europe
From €4255EUR$4,750USD£3,627GBP
- Report
- April 2023
- 115 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- September 2023
- 93 Pages
Global
From €3583EUR$4,000USD£3,054GBP
- Report
- January 2024
- 200 Pages
Global
From €3717EUR$4,150USD£3,169GBP
- Report
- June 2019
- 159 Pages
Global
From €3986EUR$4,450USD£3,398GBP
- Report
- April 2023
- 147 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- November 2021
- 120 Pages
Global
From €4031EUR$4,500USD£3,436GBP
- Report
- March 2024
- 192 Pages
Global
€4474EUR$4,995USD£3,814GBP
The Implantable Pacemaker market is a segment of the Cardiovascular Devices industry. It consists of devices that are implanted into the body to regulate the heartbeat of patients with arrhythmia. These devices use electrical pulses to stimulate the heart muscle and maintain a regular heartbeat. Implantable pacemakers are typically used to treat bradycardia, a condition in which the heart rate is too slow.
The Implantable Pacemaker market is highly competitive, with a number of companies offering a variety of devices. These companies are focused on developing innovative technologies to improve the safety and efficacy of their products. They are also investing in research and development to create new products and expand their market share.
Some of the major companies in the Implantable Pacemaker market include Medtronic, St. Jude Medical, Boston Scientific, Biotronik, Sorin Group, and LivaNova. Show Less Read more
